Our new clinical research initiative uses the bountiful basic science research resources at Albert Einstein College of Medicine to investigate the genetic, neurologic, physiologic and environmental causes of autism, learning disabilities, cerebral palsy and intellectual disabilities. By identifying the biological bases of these conditions, we hope to be able to find a cure—a treatment that will allow us to free our patients from the disabilities that adversely affect their lives.
A variety of clinical and scientific studies are currently ongoing. Included among these are clinical investigations in the early diagnosis of autism and other developmentally disabling conditions, hearing problems, genetic and electrophysiologic studies, and more. Other studies are being carried out in the areas of physical rehabilitation, speech, hearing and language development, learning disabilities, developmental dental defects, high-risk infant follow-up, social and behavioral adjustment and treatment of hyperactive children, or adolescents, and their families.
Specializing in intellectual and developmental disabilities in children and adolescents, the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC) serves as our central hub of research labs and patient clinics. Sophie Molholm, PhD, research director of the Children's Evaluation and Rehabilitation Center (CERC), directs the IDDRC's Human Clinical Phenotyping Core, which recruits and characterizes participants for Einstein studies and maintains a large database of potential research participants.